LY2874455 T2361
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
LY2874455 has been used in trials studying the treatment of Advanced Cancer.
CAS nr:
1254473-64-7
Purity:
98%
Molecular Weight:
444,31
SMILES:
C[C@H](c1c(cncc1Cl)Cl)Oc1cc2c(cc1)[nH]nc2/C=C/c1cn(nc1)CCO
Formula:
C21H19Cl2N5O2
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Angiogenesis
Target:
VEGFR,VEGFR,FGFR,FGFR
